ArticleBasic research in cardiology2021
Cardiomyocyte Na
Open access · hybridAbstract read
In one paragraph
Article in Basic research in cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.
0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
52 citing papers in PubMed, 83 citations in OpenAlex.
- Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation.The Journal of pharmacology and experimental therapeutics · 2025Trial
- Altered Acylcarnitine Metabolism in cardiac diseases: From molecular mechanisms to translational potential.International journal of cardiology. Heart & vasculature · 2026Review
- FGF23 promotes atrial fibrillation susceptibility through ETV1-dependent sodium channel regulation and calcium handling abnormalities.Experimental physiology · 2026Article
- Exploring the role of CaMKII in exercise-induced cardioprotection.Human cell · 2026Review
- Pathological Mechanisms and Therapeutic Potential of Mitochondrial Dysfunction in Heart Failure.Reviews in cardiovascular medicine · 2026Review
- Hyperglycaemia-induced reactive oxygen species production in cardiac ventricular myocytes differs among mammals.The Journal of physiology · 2026Article
- Targeting Arrhythmogenic Late Sodium Current by FHF1Circulation research · 2026Article
- Yiqi Huoxue formula relieves heart failure with reduced ejection fraction in calcium/calmodulin-dependent protein kinase Ⅱ delta B isoform and calcium/calmodulin-dependent protein kinase Ⅱ delta C isoform transgenic mice by inhibiting myocardial remodeling and enhancing calcium homeostasis.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2026Article
- Dynamic visualization of physiological CaMKII activity using sensitive FRET biosensors.bioRxiv : the preprint server for biology · 2026Article
- CaMKII as a Multimodal Signalling Hub in Neural Connectivity and Vulnerability.Molecular neurobiology · 2026Review
- A novel computational model of human iPSC-derived ventricular myocytes with improved L-type calcium current for application to Timothy syndrome.Scientific reports · 2026Article
- Article
- Excitation-contraction coupling, cardiomyocyte electrophysiology, and transcriptome profiles in two HFpEF murine models: etiology and sex-dependent differences.American journal of physiology. Heart and circulatory physiology · 2026Article
- Interplay between variability in intrinsic cellular properties and heart failure-associated remodeling in a simulated population with human heart failure.Journal of molecular and cellular cardiology · 2026Article
- Acupuncture and Metabolic-Mitochondrial Remodeling in Atrial Fibrillation: A Systematic Review and Research Recommendations.International journal of general medicine · 2026Review
- Revisiting ROS: duality in organ aging progression.Molecular biology reports · 2025Review
- PITX2 dosage-dependent changes in pacemaker cell state underlie sinus node dysfunction and atrial arrhythmias.Nature communications · 2025Article
- Article
- Mechano-energetic uncoupling in heart failure.Nature reviews. Cardiology · 2025Review
- Cardioprotective effects of semaglutide on isolated human ventricular myocardium.European journal of heart failure · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Bence HegyiDepartment of Pharmacology, University of California, Davis, 451 Health Sciences Drive, Davis, CA, 95616, USA.
Risto-Pekka PölönenDepartment of Pharmacology, University of California, Davis, 451 Health Sciences Drive, Davis, CA, 95616, USA.
Kim T HellgrenDepartment of Pharmacology, University of California, Davis, 451 Health Sciences Drive, Davis, CA, 95616, USA.
Christopher Y KoDepartment of Pharmacology, University of California, Davis, 451 Health Sciences Drive, Davis, CA, 95616, USA.
Kenneth S GinsburgDepartment of Pharmacology, University of California, Davis, 451 Health Sciences Drive, Davis, CA, 95616, USA.
Julie BossuytDepartment of Pharmacology, University of California, Davis, 451 Health Sciences Drive, Davis, CA, 95616, USA.
Mark MercolaCardiovascular Institute and Department of Medicine, Stanford University, Stanford, CA, 94305, USA.
Donald M BersDepartment of Pharmacology, University of California, Davis, 451 Health Sciences Drive, Davis, CA, 95616, USA. dmbers@ucdavis.edu.ORCID http://orcid.org/0000-0002-2237-9483
University of California, Davis · USCardiovascular Institute of the South · US
Funding
Project 3 (Mercola)P01HL141084 · NHLBI · STANFORD UNIVERSITY · PI Joseph C. Wu · 2019 to 2026
$21.1MPathophysiological Regulation of Cardiac Myocyte RyR ChannelR01HL092097 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Donald M Bers, Robyn T Rebbeck · 2010 to 2026
$9.3MCaMKII activation and regulation in adult cardiac myocytesR01HL142282 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERS, DONALD M, BOSSUYT, JULIE B · 2018 to 2025
$5.4MMicroRNA Control of Dilated CardiomyopathyR01HL130840 · NHLBI · STANFORD UNIVERSITY · PI MARK MERCOLA, Shankar Subramaniam · 2016 to 2026
$4.6MHigh-Throughput Screens to Discover Novel Inhibitors of Leaky RyR2 for Heart Failure TherapyR01HL138539 · NHLBI · UNIVERSITY OF MINNESOTA · PI BERS, DONALD M, CORNEA, RAZVAN LIVIU · 2018 to 2021
$3.1MNHLBI NIH HHS P01 HL141084NHLBI NIH HHS R01 HL092097NHLBI NIH HHS R01 HL130840NHLBI NIH HHS R01 HL138539NHLBI NIH HHS R01 HL142282NIH HHS P01-141084NIH HHS R01-142282
Abstract
Cardiomyocyte Na
Indexed as
Calcium-Calmodulin-Dependent Protein Kinase Type 2Induced Pluripotent Stem CellsAction PotentialsAnimalsCalciumFemaleHumansMyocytes, CardiacPregnancyRabbitsReactive Oxygen SpeciesRyanodine Receptor Calcium Release ChannelCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2Reactive Oxygen SpeciesRyanodine Receptor Calcium Release ChannelCalciumCaMKIIElectrophysiologyHeart failureROSRyR
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.